The corporate transformation of medicine and its impact on costs and access to care

Journal of the American Board of Family Practice

Volumn 16, Issue 5, 2003, Pages 443-454

  Geyman, John P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; GENERIC DRUG; NEW DRUG;

COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEMODIALYSIS; HUMAN; MEDICAID; MENTAL HEALTH; NURSING HOME; PRIMARY HEALTH CARE; PROFIT; REIMBURSEMENT; REVIEW; COMMERCIAL PHENOMENA; DRUG INDUSTRY; HEALTH CARE DELIVERY; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; RENAL REPLACEMENT THERAPY; SOCIAL CHANGE; UNITED STATES;

AMBULATORY CARE FACILITIES; COMMERCE; DRUG INDUSTRY; HEALTH CARE COSTS; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH; MENTAL HEALTH SERVICES; NURSING HOMES; RENAL DIALYSIS; SOCIAL CHANGE; UNITED STATES;

EID: 2342652419     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.16.5.443     Document Type: Review

References (105)

1. Relman AS. The new medical-industrial complex. N Engl J Med 1980;303:963-70.
2. Munoz R. How health care insurers avoid treating mental illness. San Diego Union Tribune 2002 May 22.
3. Stein L. Pulling the plug. Metro. Silicon Valley's Weekly Newspaper 2002 Sep 20. Available at: URL: http://www.metroactive.com/papers/metro/09.19.02/hospital-0238.html.
4. Committee on the Consequences of Uninsurance, Institute of Medicine. Shared destiny: community effects of uninsurance. Washington, DC: The National Academy Press, 2003:51.
5. Hoerger TJ. "Profit" variability in for-profit and not-for-profit hospitals. J Health Econ 1991;10:259-89.
6. Needleman J. For-profit conversions. Nonprofit to for-profit conversions by hospitals, health insurers, and health plans. Public Health Rep 1999;114:108-19.
7. Zwanziger J, Melnick GA, Bamezai A. Can cost shifting continue in a price competitive environment? Health Econ 2000;9:211-26.
8. Coye MJ. The sale of Good Samaritan: a view from the trenches. Health Aff (Millwood) 1997;16:102-7.
9. Martinez B. After an era of dominant HMOs, hospitals are turning the tables. Wall Street Journal 2002 Apr 12. Available at: URL: http://www.legacyalliance.net/Articles/News/HospitalsTurningTables.htm.
10. White RD. Tenet continuing resurgence. The Los Angeles Times. 2002 Jan 5.
11. Silverman EM, Skinner JS, Fisher ES. The association between for-profit hospital ownership and increased Medicare spending. N Engl J Med 1999;341:420-6.
12. Himmelstein DU, Woolhandler S, Hellander I. Bleeding the patient: the consequences of corporate healthcare. Monroe, ME: Common Courage Press, 2001:127-8.
13. Kuttner R. Columbia/HCA and the resurgence of the for-profit hospital business. N Engl J Med 1999;335:446-51.
14. Woolhandler S, Himmelstein DU. Costs of care and administration at for-profit and other hospitals in the United States. N Engl J Med 1997;336:769-74.
15. Hartz AJ, Krakauer H, Kuhn EM, et al. Hospital characteristics and mortality rates. N Engl J Med 1989;321:1720-5.
16. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do "America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med 1999;340:286-92.
17. Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA. The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries. Med Care 2000;38:231-45.
18. Kovner C, Gergen PJ. Nurse staffing levels and adverse events following surgery in U.S. hospitals. Image J Nurs Sch 1998;30:315-21.
19. 1998 Environmental assessment: setting foundations for the new millennium, survey. Irving, TX: VHA, Inc.; 1998.
20. Kirchner M. Will you have to join a hospital chain to survive? Med Econ 1985;62:164-76.
21. Mann JM, Melnick GA, Bamezai A, Zwanziger J. A profile of uncompensated hospital care, 1983-1995. Health Aff (Millwood) 1997;16:223-32.
22. Needleman J, Lamphere J, Chollet D. Uncompensated care and hospital conversions in Florida. Health Aff (Millwood) 1999;18:125-33.
23. Desai KR, Lukas CV, Young GJ. Public hospitals: privatization and uncompensated care. Health Aff (Millwood) 2000;19:167-72.
24. Deleted in proof.
25. Data update. PNHP Newsletter. 2002 Jan:7.
26. Abelson R. Nurses' Association says in study that big hospital chain overcharges patients for drugs. The New York Times 2002 Nov 24; Sect. 1:26.
27. Martinez B. HCA accusers may challenge U.S. settlement. The Wall Street Journal 2002 Dec 19; Sect. A:5.
28. Data update. PNHP Newsletter. Spring 2003:10.
29. Kuttner R. Must good HMOs go bad? First of two parts: the commercialism of prepaid group health care. N Engl J Med 1998;338:1558-63.
30. Comparing Medicare HMOs. Do they keep their members? Washington, DC: Families USA, 1997.
31. When things go wrong. Consumer Reports 1996;62(8):39-42.
32. Himmelstein DU, Woolhandler S, Hellander I, Wolfe SM. Quality of care in investor-owned vs not-for-profit HMOs. JAMA 1999;282:159-63.
33. The HMO honor roll. U.S. News & World Report 1997 Oct 23:62.
34. Kuttner R. The American health care system: Wall Street and health care. N Engl J Med 1999;340:664-8.
35. Duff C. Americans tell government to stay out - except in case of health care. The Wall Street Journal 1998 Jun 25; Sect. A:9,14.
36. Pollitz K, Crowley J, Lucia K, Bangit E. Assessing state external review programs and the effects of pending Federal patients' rights legislation. Menlo Park, CA: Henry J. Kaiser Family Foundation, 2002.
37. Rush Prudential HMO Inc v Moran (00-1021), 230 F3d 959, affirmed. Available at: URL: http://www.supremecourtus.gov/opinions/01pdf/00-1021.pdf
38. Rice B. When an HMO denial is practicing medicine. Med Econ 2002;79:100, 103, 107.
39. McCormick D, Himmelstein DU, Woolhandler S, Wolfe SM, Bor DH. Relationship between low quality-of-care scores and HMOs subsequent public disclosure of quality-of-care scores. JAMA 2002;288:1484-90.
40. Court J, Smith F. Making a killing: HMOs and the threat to your health. Monroe, ME: Common Courage Press, 1999.
41. Peeno L. HMOs seek whitewash instead of facing misdeeds. The Wall Street Journal 2002 Jul 26; Sect. A:11.
42. Lee D. A bright spot in health insurance. The Los Angeles Times 2002 Apr 25; Sect. C:1.
43. Waldholz M. Prescriptions. Medicare seniors face confusion as HMOs bail out of program. The Wall Street Journal 2002 Oct 3; Sect. D:4.
44. Barry P. More HMOs leave Medicare. AARP Bulletin 2002 Nov;43:1.
45. Lowes R. We nailed an HMO for $6 million. Med Econ 2002;79(24):60-2, 65-7.
46. Lee D. Rising costs put pressure on Kaiser. The Los Angeles Times 2002 Sep 29.
47. Competition in the markets. On Managed Care 2001 Apr;6:1.
48. Song KM. Hospitals sue Premera to halt for-profit switch. Seattle Times 2003 Jan 23; Sect. A:1.
49. Kuttner R. Everything for sale: the virtues and limits of markets. Chicago: University of Chicago Press, 1999.
50. News release. FTCR calls for health care rate regulation. Santa Monica, CA: The Foundation for Taxpayer and Consumer Rights, 2002 Oct 4.
51. Benko LB. Managed care. Shakeup in California. Modern Healthcare. 2002 May 13;32.
52. Terhune C. Side effect. Insurer's tactic: if you get sick, the premium rises. The Wall Street Journal 2002 Apr 9; Sect. A:1.
53. Morrison AB, Wolfe SM. Outrage of the month. None of your business. Public Citizen's Health Research Group Health Letter 2001;17(2):11.
54. Terhune C. Insurers avoid state regulations by selling via groups elsewhere. The Wall Street Journal 2002 Apr 9;Sect. A:20.
55. Terhune C. Non-profit groups that tout insurance have hidden links. The Wall Street Journal 2002 Nov 21;Sect. A.
56. Tep R. Click here for coverage. Forbes.com. 2002 Nov 21. Available at: URL: http://www.forbes.com/best/2002/1202/005.html
57. Martinez B. Cigna is stung in ploy to settle rival lawsuits. The Wall Street Journal 2002 Dec 20; Sect. B:1.
58. McGinley L. General American to pay $76 million in Medicare case. The Wall Street Journal 2002 Jun 26;Sect. A:2.
59. Managed Healthcare Market Report. March 2001: 31.
60. Public Citizen Report. April 18, 2002. Pharmaceutical industry ranks as most profitable industry - again. Public Citizen Report. 2002 Apr 18. Available at: URL: http://www.citizen.org/pressroom/release.cfm?ID=1088.
61. Mintz M. Still hard to swallow. The Washington Post 2001 Feb; Health.
62. Public Citizen Report. 2001 Jul.
63. Relman AS, Angell M. America's other drug problem: how the drug industry distorts medicine and politics. The New Republic 2002 Dec 16;27-41.
64. Baker D. Patent medicine. The American Prospect 2001 Jan 29:34-5.
65. Editorial. Gaming the patent drug system. The Los Angeles Times 2002 June:10.
66. Ivins M. Drug companies antics can really make you sick. Public Citizen's Health Research Group Health Letter 2001;17(7):4.
67. GPHA rips PhRMA ad. O'Dwyer's PR Services Report 2002 Nov:15.
68. Baglole J. Glaxo tries new tack on cheap Canadian drugs. The Wall Street Journal. 2003 Jan 22;Sect. D:2.
69. Angell M, Relman AE. Prescription for profit. The Washington Post 2001 Jun 20;Sect. A:27
70. CBS. 60 Minutes. December 1999:r19.
71. Deyo RA, Psaty BM, Simon G, Wagner EH, Omenn GS. The messenger under attack - intimidation of researchers by special-interest groups. N Engl J Med 1997;336:1176-80.
72. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003;326:45-7.
73. Chartrand S. Patents: the Viagra counterpart for women is on its way and it addresses a clinical condition new to the popular lexicon. The New York Times 2003 Jan 27;Sect. C:7.
74. Wolfe SM. Direct-to-consumer (DTC) ads: illegal, unethical or both. Public Citizen's Health Research Group Health Letter 2001;17(9):3.
75. Wolfe SM. Update on the illegal promotion of gabapentin (Neurontin). Public Citizen's Health Research Group Health Letter 2002;18(8):3-5.
76. Wolfe SM. Unsafe drugs: congressional silence is deadly (part 2). Public Citizen's Health Research Group Health Letter 2002;18(9):1-4.
77. DHHS. Inspector General report and New York Times. Associated Press Report. September 20;2001.
78. Press release. Families USA. July 2002:17.
79. Kihlstrom LC. Characteristics and growth of managed behavioral health care firms. Health Aff (Millwood) 1997;16:127-30.
80. Wrich J. Brief summary of audit findings of managed behavioral health services. Chicago, IL: J. Wrich & Associates, Inc., 1998.
81. Garg PP, Frick KD, Diener-West M, Powe NR. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med 1999;341:1653-60.
82. Devereaux PJ, Schunemann HJ, Ravindran N, et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA 2002;288:2449-57.
83. Press release. Settlement with Fresenius Medical Care. Washington, DC: Office of Inspector General, US Department of Health and Human Services; 2000 Jan 19.
84. Pear R. Government is called lenient toward errant nursing homes. The New York Times. 1998 Jul 27.
85. Wolfe SM. Neglected to death: the scandalous condition of American nursing homes. Public Citizen's Research Group Health Letter 2003;19:1-4.
86. Mod Healthc 2000 Feb 7;30(6).
87. Sullivan K. Strangled competition: a critique of Minnesota's experiment with managed competition. St. Paul, MN: Minnesota COACT and COACT Education Foundation, 1995.
88. Findley S. Research brief. National Institute for Health Care Management Research and Educational Foundation. Med Benefits 2000;17:5-6.
89. Woolhandler S, Himmelstein DU. When money is the mission - the high costs of investor-owned care. N Engl J Med 1999;341:444-6.
90. Appleby J. More high-income Americans go without health insurance. USA Today 2002 Nov 22; Sect. B:1.
91. Health Insurance Coverage in America: 2000 data update. Menlo Park, CA: Kaiser Commission on Medicaid and the Uninsured, 2002:9. Available at: URL: http://www.kff.org/content/2002/4007/4007.pdf
92. Data update. PNHP Newsletter. Jan 2002:6.
93. Woolhandler S, Himmelstein DU. Paying for national health insurance - and not getting it. Health Aff (Millwood) 2002;21:88-98.
94. Findley S. Bridge temporary insurance gaps. USA Today 2002 Sep 26;Sect. A:11.
95. Institute of Medicine Report. October 2001:11.
96. Swartz K. Who owns the problem of the uninsured? Inquiry 1996;33:103-5.
97. Committee on the Consequences of Uninsurance. Health insurance is a family matter. Washington, DC: The National Academy Press, 2002:1-10.
98. Hadley J. Sicker and poorer: the consequences of being uninsured. Menlo Park, CA: Kaiser Commission on Medicaid and the uninsured. Kaiser Family Foundation, 2002.
99. Billings J, Minanoviteh T, Blank A. Barriers to care for patients with preventable hospital admissions. New York: United Hospital Fund, 1997.
100. Baker DW, Sudano JJ, Albert JM, Borawski EA, Dor A. Lack of health insurance and decline in overall health in late middle age. N Engl J Med 2001;345:1106-12.
101. Cunningham PJ. Prescription drug access: not just a Medicare problem. Issue brief no. 51. Washington, DC: Center for Studying Health System Change, 2002. Available at: URL: http://www.hschange.com/CONTENT/429/
102. Wagner L. Citing national losses of $2.2 billion, physicians closing doors to seniors. Physician Financial News 2002 May 15;20:1, 24.
103. Institute for the Future. Health and Health Care 2010: the forecast, the challenges. San Francisco: Jossey-Bass, 2000;123-37.
104. Health spending to double. Practice Trends. Policy & Practice. Fam Pract News 2003;33:53.
105. Renzulli D. Capitol offenders: how private interests govern our states. Washington, DC: Public Integrity Books, 2002:149-66.